LENZ Therapeutics, Inc. LENZ Q2 2025 earnings
Reported July 30, 2025 · Before market open
Revenue$5.0MBeat by $4.3M
EPS-$0.53Beat by $0.05
Revenue estimate$714.3K
EPS estimate-$0.58
Next report
Jul 29, 2026 (Today)Revenue estimate$2.4M
EPS estimate-$1.05
Versus estimates
Revenue
Q1 2026$1.9MBeat by $142.1KQ4 2025$1.6MMiss by $1.5MQ3 2025$12.5MBeat by $9.5M
Q2 2025$5.0MBeat by $4.3M
Diluted EPS
Ask the moment LENZ Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did LENZ Therapeutics, Inc. report Q2 2025 earnings?
- LENZ Therapeutics, Inc. (LENZ) reported Q2 2025 earnings on July 30, 2025 before market open.
- What were LENZ Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- LENZ Therapeutics, Inc. reported revenue of $5.0M and eps of $-0.53 for Q2 2025.
- Did LENZ Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $714.3K by $4.3M. EPS beat the consensus estimate of $-0.58 by $0.05.
- How did LENZ Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 32.5% from $-0.40.
- Where can I find LENZ Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001815776-25-000056) directly on SEC EDGAR. The filing index links above go to sec.gov.